GlassScriptPhysician profile
Manish B Patel
NPI 1962765461
$5,398.14
in general payments reported to CMS, 2019-2025
23 companies · $339 in 2025
The $339 reported for 2025 was more than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,960 · 2020: $1,251 · 2021: $213 · 2022: $329 · 2023: $868 · 2024: $440 · 2025: $339.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,111 · Travel and Lodging: $535.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,111.16 |
| Travel and Lodging | $534.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $1,685.03 | 2019 | |
| Seapearl East, INC | $615.12 | 2020 | |
| Abiomed | $534.87 | 2023 | Impella |
| Spinal Simplicity, LLC | $316.37 | 2024-2025 | Ha Minuteman G3-R |
| Spr Therapeutics, INC | $281.72 | 2022-2025 | Sprint Pns System |
| Stimwave Technologies Incorporated | $281.65 | 2020 | |
| Abbvie INC. | $260.50 | 2022-2025 | |
| Arteriocyte Medical Systems, INC. | $234.10 | 2020 | |
| Stratus Medical, LLC | $221.79 | 2023 | Nimbus |
| Medtronic, INC. | $204.73 | 2021-2025 | Synchromedii, Intellis Adaptivestim |
| Alexion Pharmaceuticals, INC. | $130.29 | 2024-2025 | Strensiq |
| Amarin Pharma, INC. | $125.00 | 2019 | |
| Abbott Laboratories | $118.25 | 2019 | |
| Cardiovascular Systems INC. | $107.08 | 2020 | |
| Orthofix Medical, INC. | $80.16 | 2023 | Spinal-Stim, Spinal-Stim |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fidia Pharma USA INC. | $58.82 | 2021-2023 | Hymovis, Triluron |
| Smith+Nephew, INC. | $31.49 | 2019 | |
| Nalu Medical, INC. | $30.48 | 2024 | Nalu Neurostimulation System |
| Depuy Synthes Sales INC. | $22.36 | 2022 | |
| Kyowa Kirin, INC. | $18.03 | 2024 | Crysvita |
| Tersera Therapeutics LLC | $14.82 | 2025 | Prialt |
| Boston Scientific Corporation | $12.78 | 2020 | |
| Avanos Medical | $12.70 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Manish Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.